Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 217

1.

Effects of lifestyle intervention in BRCA1/2 mutation carriers on nutrition, BMI, and physical fitness (LIBRE study): study protocol for a randomized controlled trial.

Kiechle M, Engel C, Berling A, Hebestreit K, Bischoff SC, Dukatz R, Siniatchkin M, Pfeifer K, Grill S, Yahiaoui-Doktor M, Kirsch E, Niederberger U, Enders U, Löffler M, Meindl A, Rhiem K, Schmutzler R, Erickson N, Halle M.

Trials. 2016 Jul 29;17:368. doi: 10.1186/s13063-016-1504-0.

2.

Nutritional influences of overfeeding on experimental outcomes in laboratory mice: consequences for gut microbiota and other functional studies.

Bischoff SC, Volynets V.

Int J Med Microbiol. 2016 Aug;306(5):328-33. doi: 10.1016/j.ijmm.2016.05.018. Epub 2016 Jun 3.

PMID:
27432516
3.

Loss of lipopolysaccharide-binding protein attenuates the development of diet-induced non-alcoholic fatty liver disease (NAFLD) in mice.

Jin CJ, Engstler AJ, Ziegenhardt D, Bischoff SC, Trautwein C, Bergheim I.

J Gastroenterol Hepatol. 2016 Jul 12. doi: 10.1111/jgh.13488. [Epub ahead of print]

PMID:
27404046
4.

Impact of a High-Fat or High-Fiber Diet on Intestinal Microbiota and Metabolic Markers in a Pig Model.

Heinritz SN, Weiss E, Eklund M, Aumiller T, Heyer CM, Messner S, Rings A, Louis S, Bischoff SC, Mosenthin R.

Nutrients. 2016 May 23;8(5). pii: E317. doi: 10.3390/nu8050317.

5.

Intestinal Microbiota and Microbial Metabolites Are Changed in a Pig Model Fed a High-Fat/Low-Fiber or a Low-Fat/High-Fiber Diet.

Heinritz SN, Weiss E, Eklund M, Aumiller T, Louis S, Rings A, Messner S, Camarinha-Silva A, Seifert J, Bischoff SC, Mosenthin R.

PLoS One. 2016 Apr 21;11(4):e0154329. doi: 10.1371/journal.pone.0154329. eCollection 2016.

6.

Analysis of factors contributing to variation in the C57BL/6J fecal microbiota across German animal facilities.

Rausch P, Basic M, Batra A, Bischoff SC, Blaut M, Clavel T, Gläsner J, Gopalakrishnan S, Grassl GA, Günther C, Haller D, Hirose M, Ibrahim S, Loh G, Mattner J, Nagel S, Pabst O, Schmidt F, Siegmund B, Strowig T, Volynets V, Wirtz S, Zeissig S, Zeissig Y, Bleich A, Baines JF.

Int J Med Microbiol. 2016 Aug;306(5):343-55. doi: 10.1016/j.ijmm.2016.03.004. Epub 2016 Mar 15.

7.

Citrus peel polymethoxyflavones nobiletin and tangeretin suppress LPS- and IgE-mediated activation of human intestinal mast cells.

Hagenlocher Y, Feilhauer K, Schäffer M, Bischoff SC, Lorentz A.

Eur J Nutr. 2016 Mar 28. [Epub ahead of print]

PMID:
27021766
8.

Cinnamon extract reduces symptoms, inflammatory mediators and mast cell markers in murine IL-10(-/-) colitis.

Hagenlocher Y, Hösel A, Bischoff SC, Lorentz A.

J Nutr Biochem. 2016 Apr;30:85-92. doi: 10.1016/j.jnutbio.2015.11.015. Epub 2015 Dec 11.

PMID:
27012624
9.

ESPEN guideline on ethical aspects of artificial nutrition and hydration.

Druml C, Ballmer PE, Druml W, Oehmichen F, Shenkin A, Singer P, Soeters P, Weimann A, Bischoff SC.

Clin Nutr. 2016 Jun;35(3):545-56. doi: 10.1016/j.clnu.2016.02.006. Epub 2016 Feb 16.

PMID:
26923519
10.

Characterization of the Gut Microbial Community of Obese Patients Following a Weight-Loss Intervention Using Whole Metagenome Shotgun Sequencing.

Louis S, Tappu RM, Damms-Machado A, Huson DH, Bischoff SC.

PLoS One. 2016 Feb 26;11(2):e0149564. doi: 10.1371/journal.pone.0149564. eCollection 2016.

11.

Mast cells in gastrointestinal disorders.

Bischoff SC.

Eur J Pharmacol. 2016 May 5;778:139-45. doi: 10.1016/j.ejphar.2016.02.018. Epub 2016 Feb 4.

PMID:
26852959
12.

Gastric ghrelin, GOAT, leptin, and leptinR expression as well as peripheral serotonin are dysregulated in humans with obesity.

Ritze Y, Schollenberger A, Hamze Sinno M, Bühler N, Böhle M, Bárdos G, Sauer H, Mack I, Enck P, Zipfel S, Meile T, Königsrainer A, Kramer M, Bischoff SC.

Neurogastroenterol Motil. 2016 Jun;28(6):806-15. doi: 10.1111/nmo.12773. Epub 2016 Jan 19.

PMID:
26787056
13.

Impact of protein supplementation after bariatric surgery: A randomized controlled double-blind pilot study.

Schollenberger AE, Karschin J, Meile T, Küper MA, Königsrainer A, Bischoff SC.

Nutrition. 2016 Feb;32(2):186-92. doi: 10.1016/j.nut.2015.08.005. Epub 2015 Sep 1.

PMID:
26691769
14.

Microbiota and aging.

Bischoff SC.

Curr Opin Clin Nutr Metab Care. 2016 Jan;19(1):26-30. doi: 10.1097/MCO.0000000000000242.

PMID:
26560527
15.

Assessment of the Intestinal Barrier with Five Different Permeability Tests in Healthy C57BL/6J and BALB/cJ Mice.

Volynets V, Reichold A, Bárdos G, Rings A, Bleich A, Bischoff SC.

Dig Dis Sci. 2016 Mar;61(3):737-46. doi: 10.1007/s10620-015-3935-y. Epub 2015 Oct 31.

PMID:
26520109
16.

Altered intestinal neuroendocrine gene expression in humans with obesity.

Ritze Y, Hengelhaupt C, Bárdos G, Ernst B, Thurnheer M, D'Haese JG, Bischoff SC, Schultes B.

Obesity (Silver Spring). 2015 Nov;23(11):2278-85. doi: 10.1002/oby.21253. Epub 2015 Sep 18.

PMID:
26381270
17.

Standard operating procedures for ESPEN guidelines and consensus papers.

Bischoff SC, Singer P, Koller M, Barazzoni R, Cederholm T, van Gossum A.

Clin Nutr. 2015 Dec;34(6):1043-51. doi: 10.1016/j.clnu.2015.07.008. Epub 2015 Jul 16.

PMID:
26254807
18.

Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption.

Damms-Machado A, Mitra S, Schollenberger AE, Kramer KM, Meile T, Königsrainer A, Huson DH, Bischoff SC.

Biomed Res Int. 2015;2015:806248. doi: 10.1155/2015/806248. Epub 2015 Feb 1.

19.

Should ESPEN engage in facing the obesity challenge?

Barazzoni R, Van Gossum A, Singer P, Bischoff SC.

Clin Nutr. 2015 Apr;34(2):169-70. doi: 10.1016/j.clnu.2015.01.002. Epub 2015 Jan 13. No abstract available.

PMID:
25637248
20.
Items per page

Supplemental Content

Loading ...
Write to the Help Desk